OPRX

MKT CAP:$121M

OptimizeRx Corporation

Market Cap

$121M

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$7.12-$5.30 (-42.67%)

Apr 21, 2026

Company Details

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patie...

CEO

Stephen L. Silvestro

IPO Date

Nov 28, 2007

Website

www.optimizerx.com

Key Metrics TTM

Revenue

$109M

+18.8% YoY

Net Income

$5M

EPS (Diluted)

$0.26

Free Cash Flow

$19M

Revenue / Share

$5.65

Gross Margin

63.3%

Operating Margin

11.0%

Net Margin

4.7%

FCF Margin

17.0%

P/S

1.1x

P/E

23.5x

Earnings Reports

Q1 2026

May 11, 2026

PENDING

FY 2025

Mar 12, 2026

$109M+18.8%EPS $0.27

Q4 2025

Mar 12, 2026

$32M-0.2%EPS $0.26

Q3 2025

Nov 7, 2025

$26M+22.3%EPS $0.04

Q2 2025

Aug 8, 2025

$29M+55.2%EPS $0.08

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$14M	$8M	-$4M
Q2 22	$14M	$9M	-$4M
Q3 22	$15M	$9M	-$4M
Q4 22	$20M	$12M	-$864.3K
Q1 23	$13M	$7M	-$7M
Q2 23	$14M	$8M	-$5M
Q3 23	$16M	$10M	-$4M
Q4 23	$28M	$18M	-$11M
Q1 24	$20M	$12M	-$5M
Q2 24	$19M	$12M	-$4M
Q3 24	$21M	$13M	-$9M
Q4 24	$32M	$22M	$4M
Q1 25	$22M	$13M	-$2M
Q2 25	$29M	$19M	$3M
Q3 25	$26M	$18M	$2M
Q4 25	$32M	$20M	$9M

Valuation

Quarter	P/S	P/E
Q1 22	1.9x	—
Q2 22	1.9x	—
Q3 22	1.9x	—
Q4 22	1.9x	—
Q1 23	2.0x	—
Q2 23	2.0x	—
Q3 23	1.9x	—
Q4 23	1.7x	—
Q1 24	1.5x	—
Q2 24	1.4x	—
Q3 24	1.4x	—
Q4 24	1.3x	—
Q1 25	1.3x	—
Q2 25	1.2x	—
Q3 25	1.1x	3548.3x
Q4 25	1.1x	23.5x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$4M	$4M
Q2 22	$308.1K	$281.3K
Q3 22	$3M	$3M
Q4 22	$3M	$3M
Q1 23	-$86.3K	-$114.9K
Q2 23	-$2M	-$2M
Q3 23	$1M	$1M
Q4 23	-$6M	-$6M
Q1 24	$2M	$2M
Q2 24	$782.0K	$697.0K
Q3 24	$2M	$2M
Q4 24	$198.0K	$78.0K
Q1 25	$4M	$4M
Q2 25	$5M	$5M
Q3 25	$3M	$3M
Q4 25	$7M	$7M

Capital Expenditures

Quarter	CapEx
Q1 22	$65.8K
Q2 22	$26.9K
Q3 22	$36.4K
Q4 22	$21.6K
Q1 23	$28.6K
Q2 23	$20.0K
Q3 23	$321.2K
Q4 23	$5.3K
Q1 24	$153.0K
Q2 24	$85.0K
Q3 24	$92.0K
Q4 24	$120.0K
Q1 25	$27.0K
Q2 25	$10.0K
Q3 25	$10.0K
Q4 25	$11.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+22.3%	+47.4%
Q2 22	+2.6%	+34.6%
Q3 22	-6.4%	+17.1%
Q4 22	-3.2%	+4.2%
Q1 23	-5.3%	+14.7%
Q2 23	-1.1%	+4.4%
Q3 23	+8.3%	+5.5%
Q4 23	+44.3%	+91.4%
Q1 24	+51.4%	+23.2%
Q2 24	+36.1%	+20.9%
Q3 24	+30.5%	+50.2%
Q4 24	+13.9%	-27.0%
Q1 25	+11.4%	-2.7%
Q2 25	+55.2%	+15.3%
Q3 25	+22.3%	-19.6%
Q4 25	-0.2%	-18.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$3M	23.1%
Q2 22	$4M	28.8%
Q3 22	$4M	28.4%
Q4 22	$4M	21.7%
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$3M	19.6%
Q4 23	$3M	9.3%
Q1 24	$3M	15.4%
Q2 24	$3M	15.4%
Q3 24	$3M	12.2%
Q4 24	$3M	9.1%
Q1 25	$2M	7.1%
Q2 25	$1M	5.1%
Q3 25	$2M	7.5%
Q4 25	$2M	6.1%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 22	—	$11M	$36.1K
Q2 22	—	$12M	—
Q3 22	—	$13M	—
Q4 22	—	$15M	—
Q1 23	—	$14M	—
Q2 23	—	$12M	—
Q3 23	$48.0K	$13M	$30.0K
Q4 23	—	$19M	—
Q1 24	$71.0K	$16M	—
Q2 24	$71.0K	$14M	—
Q3 24	$91.0K	$13M	—
Q4 24	—	$17M	—
Q1 25	$91.0K	$14M	—
Q2 25	—	$14M	—
Q3 25	$80.0K	$14M	$60.0K
Q4 25	—	$12M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$89M	$0	$89M
Q2 22	$87M	$0	$87M
Q3 22	$41M	$37M	$79M
Q4 22	$18M	$56M	$74M
Q1 23	$16M	$57M	$74M
Q2 23	$10M	$53M	$63M
Q3 23	$10M	$54M	$64M
Q4 23	$14M	$0	$14M
Q1 24	$15M	$0	$15M
Q2 24	$15M	$0	$15M
Q3 24	$16M	$0	$16M
Q4 24	$13M	$0	$13M
Q1 25	$17M	$0	$17M
Q2 25	$17M	$0	$17M
Q3 25	$20M	$0	$20M
Q4 25	$23M	$0	$23M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	18M	-1.8%	+11.0%
Q2 22	18M	+1.4%	+0.1%
Q3 22	18M	-0.8%	-1.2%
Q4 22	18M	-0.5%	-1.7%
Q1 23	17M	-4.4%	-4.4%
Q2 23	17M	-0.6%	-6.2%
Q3 23	17M	-2.1%	-7.5%
Q4 23	18M	+6.1%	-1.3%
Q1 24	18M	+3.0%	+6.3%
Q2 24	18M	+0.5%	+7.4%
Q3 24	18M	+0.4%	+10.1%
Q4 24	18M	+0.5%	+4.4%
Q1 25	18M	+0.3%	+1.7%
Q2 25	19M	+2.9%	+4.1%
Q3 25	19M	+0.0%	+3.8%
Q4 25	19M	+1.9%	+5.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$167.5K	82
Q2 22	$170.5K	82
Q3 22	$184.0K	82
Q4 22	$209.1K	94
Q1 23	$138.3K	94
Q2 23	$147.0K	94
Q3 23	$173.7K	94
Q4 23	$244.6K	116
Q1 24	$169.7K	116
Q2 24	$162.2K	116
Q3 24	$183.7K	116
Q4 24	$304.9K	106
Q1 25	$206.9K	106
Q2 25	$275.4K	106
Q3 25	$245.9K	106
Q4 25	$310.0K	104

Revenue / Employee